Select Your Region
Americas
Europe
Africa
Global
Profile settings
Update your username and manage your account
Search results
Review the results we have found for you.
Use the filters to narrow down the results list and easily find the study you look for.
Refine your search
Search
Alzheimer's Disease (AD)
Location
Please note that the recruitment status of the study at your site may differ from the overall study status because some study sites may recruit earlier than others.
We found 23 results for 'ALZHEIMER'S DISEASE (AD)'Use the filters to narrow down your search.
1 
Study StatusRecruiting1 A clinical trial to look at how well RO7269162 works in people who are at risk of Alzheimer’s disease or who have mild cognitive impairment due to Alzheimer’s disease and how safe RO7269162 is at different doses
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT06402838, BP44745, 2023-506183-13-00
2 
Study StatusActive, not recruiting2 A study to state how safe RO7126209 is at different doses and how the body processes RO7126209
Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT04639050, BP42155, 2020-002477-98,2023-509678-52-00
3 
Study StatusCompleted3 Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT02792179, BP39126
4 Study StatusCompleted4 A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT02820896, GN39058
5 Study StatusCompleted5 A Study of the Biodistribution and Safety of [18F]GTP1 in Healthy Japanese Participants
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT04394845, GN42043
6 Study StatusCompleted6 Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT02640092, GN30009, G0097
7 Study StatusCompleted7 A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT02353598, GN29632
8 Study StatusCompleted8 A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT01224106, WN25203, 2010-019895-66
9 Study StatusCompleted9 A Study of Gantenerumab in Participants With Mild Alzheimer Disease
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT02051608, WN28745, 2013-003390-95
10 Study StatusCompleted10 Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT03977584, BN40199